GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GSK GlaxoSmithKline PLC

Closed 07-16 16:00:00 EDT

52.77

+1.32

+2.57%

盘后52.75

-0.02-0.03%

19:41 EDT

High52.85	Low51.40	Vol3.98M
Open51.48	D1 Closing51.45	Amplitude2.82%
Mkt Cap106.74B	Tradable Cap102.74B	Total Shares2.02B
T/O209.40M	T/O Rate0.20%	Tradable Shares1.95B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GSK","market":"US","secType":"STK","nameCN":"GlaxoSmithKline PLC","latestPrice":52.77,"timestamp":1784232000000,"preClose":51.45,"halted":0,"volume":3978763,"hourTrading":{"tag":"盘后","latestPrice":52.7541,"preClose":52.77,"latestTime":"19:41 EDT","volume":483153,"amount":25496187.106,"timestamp":1784245287499,"change":-0.0159,"changeRate":-0.000301,"amplitude":0.004169},"delay":0,"changeRate":0.025655976676384844,"floatShares":1946891708,"shares":2022697682,"eps":3.736205,"marketStatus":"Closed","change":1.32,"latestTime":"07-16 16:00:00 EDT","open":51.48,"high":52.85,"low":51.4,"amount":209397900.156885,"amplitude":0.028183,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.736205,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1784275200000},"marketStatusCode":5,"adr":1,"adrRate":2,"listingDate":977893200000,"exchange":"NYSE","adjPreClose":51.45,"dividendRate":0.033779,"preHourTrading":{"tag":"盘前","latestPrice":51.55,"preClose":51.45,"latestTime":"09:25 EDT","volume":16668,"amount":863085.708,"timestamp":1784208338047,"change":0.1,"changeRate":0.001944,"amplitude":0.01069},"postHourTrading":{"tag":"盘后","latestPrice":52.7541,"preClose":52.77,"latestTime":"19:41 EDT","volume":483153,"amount":25496187.106,"timestamp":1784245287499,"change":-0.0159,"changeRate":-0.000301,"amplitude":0.004169},"volumeRatio":1.485487,"impliedVol":0.3446,"impliedVolPercentile":0.8725},"requestUrl":"/m/hq/s/GSK","defaultTab":"news","newsList":[{"id":"2652042578","title":"GSK Advances New Infant Pneumococcal Vaccine Into Early-Stage Testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2652042578","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652042578?lang=en_us&edition=fundamental","pubTime":"2026-07-17 00:31","pubTimestamp":1784219518,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline is launching a Phase 1 trial to test an infant pneumoco...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-advances-new-infant-pneumococcal-vaccine-into-early-stage-testing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-advances-new-infant-pneumococcal-vaccine-into-early-stage-testing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","BBC","BK4588","GSKH","GSK.UK","BK4007","BK4585","LU1829250122.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652425680","title":"GSK Rises Thursday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2652425680","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652425680?lang=en_us&edition=fundamental","pubTime":"2026-07-17 00:08","pubTimestamp":1784218080,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.GSK PLC  shares advanced 2.06% to GBP19.56 Thursday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index  rising 0.54% to 10,572.24.GSK PLC closed 14.29% short of its 52-week high of GBP22.82, which the company reached on February 18th.Trading volume totaled 3.9 million, compared to the 50-day average of 7.8 million.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 16, 2026 12:08 ET Copyright  2026 Dow Jones & Company, Inc.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651428983","title":"GSK executives boost holdings via dividend-funded ADS purchases","url":"https://stock-news.laohu8.com/highlight/detail?id=2651428983","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651428983?lang=en_us&edition=fundamental","pubTime":"2026-07-16 22:32","pubTimestamp":1784212352,"startTime":"0","endTime":"0","summary":"The latest update is out from GlaxoSmithKline ( ($GB:GSK) ). GSK has disclosed a series of transactions in which several senior executives and non-...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-executives-boost-holdings-via-dividend-funded-ads-purchases?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-executives-boost-holdings-via-dividend-funded-ads-purchases?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","GSK.UK","BK4585","GSKH","BK4007","BK4588","VIG","BK4532","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651467645","title":"GSK’s New Phase 3 Ovarian Cancer Trial Puts Mo-Rez in the First-Line Spotlight","url":"https://stock-news.laohu8.com/highlight/detail?id=2651467645","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651467645?lang=en_us&edition=fundamental","pubTime":"2026-07-16 00:31","pubTimestamp":1784133105,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is launching a phase 3 trial called BEHOLD-Ovaria...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-new-phase-3-ovarian-cancer-trial-puts-mo-rez-in-the-first-line-spotlight?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-new-phase-3-ovarian-cancer-trial-puts-mo-rez-in-the-first-line-spotlight?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","BK4588","BK4585","GSKH","GSK","BK4007","BK4532","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651846405","title":"Is AnaptysBio (ANAB) Undervalued Following Its Jemperli Royalty Appeal And GSK Trial?","url":"https://stock-news.laohu8.com/highlight/detail?id=2651846405","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651846405?lang=en_us&edition=fundamental","pubTime":"2026-07-15 22:36","pubTimestamp":1784126191,"startTime":"0","endTime":"0","summary":"Laughing Water Capital’s recent decision to add AnaptysBio (ANAB) has drawn attention because it hinges on two factors: royalty income from the cancer drug Jemperli and an imminent commercial trial with partner GSK.\nSee our latest analysis for AnaptysBio.\nDespite the recent legal spotlight, AnaptysBio’s share price has been volatile, with a 1-day share price return down 10.46% and a 7-day share price return down 7.15%. However, a year-to-date share price return of 39.07% sits alongside a very...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-anab/anaptysbio/news/is-anaptysbio-anab-undervalued-following-its-jemperli-royalt","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-anab/anaptysbio/news/is-anaptysbio-anab-undervalued-following-its-jemperli-royalt","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4532","BK4139","GSKH","BK4007","GSK","BK4588","ANAB","GSK.UK","BK4585","LU1829250122.USD","FFTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651690154","title":"GSK Completes $10.6 Billion Acquisition of Nuvalent","url":"https://stock-news.laohu8.com/highlight/detail?id=2651690154","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651690154?lang=en_us&edition=fundamental","pubTime":"2026-07-15 22:16","pubTimestamp":1784124997,"startTime":"0","endTime":"0","summary":"GSK  said Wednesday it has completed the acquisition of Nuvalent , a Boston-based clinical-stage biopharmaceutical company, in a transaction with an aggregate equity value of about $10.6 billion.The transaction, which represents a net investment of about $9.4 billion after accounting for acquired cash, was finalized through a tender offer for all outstanding Nuvalent shares.The deal adds three lung cancer assets to GSK's oncology portfolio, according to a statement.Price: 51.55, Change: +0.30, Percent Change: +0.58","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LU1829250122.USD","BK4532","NUVL","BK4539","GSK","BK4588","GSK.UK","GSKH","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651100990","title":"GSK Slides Tuesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2651100990","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651100990?lang=en_us&edition=fundamental","pubTime":"2026-07-15 00:07","pubTimestamp":1784045220,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of GSK PLC  slipped 1.69% to GBP19.21 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index  rising 0.30% to 10,529.39.GSK PLC closed 15.84% short of its 52-week high of GBP22.82, which the company achieved on February 18th.Trading volume totaled 3.7 million, compared to the 50-day average of 7.8 million.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 14, 2026 12:07 ET Copyright  2026 Dow Jones & Company, Inc.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651110571","title":"GSK Executives Acquire Shares Under Routine Reward Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2651110571","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651110571?lang=en_us&edition=fundamental","pubTime":"2026-07-13 22:32","pubTimestamp":1783953145,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has provided an update. GSK has disclosed multiple small share acquisitions by senior executives under the company’s ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-executives-acquire-shares-under-routine-reward-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-executives-acquire-shares-under-routine-reward-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4532","BK4588","GSK.UK","GSK","LU1829250122.USD","GSKH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651511137","title":"UBS Remains a Hold on GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651511137","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651511137?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:16","pubTimestamp":1783944989,"startTime":"0","endTime":"0","summary":"UBS analyst Matthew Weston maintained a Hold rating on GlaxoSmithKline today and set a price target of £19.40. According to TipRanks, Weston is a 4...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ubs-remains-a-hold-on-glaxosmithkline-gsk-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ubs-remains-a-hold-on-glaxosmithkline-gsk-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4532","BK4007","GSK","BK4588","GSKH","LU1829250122.USD","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651954591","title":"GSK’s Jemperli Trial Points to Chemo‑Free Future for Subset of Rectal Cancer Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2651954591","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651954591?lang=en_us&edition=fundamental","pubTime":"2026-07-13 14:09","pubTimestamp":1783922982,"startTime":"0","endTime":"0","summary":"The latest update is out from GlaxoSmithKline ( ($GB:GSK) ). GSK has reported positive interim phase II AZUR-1 data for its PD‑1 inhibitor Jemperli...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-jemperli-trial-points-to-chemofree-future-for-subset-of-rectal-cancer-patients?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-jemperli-trial-points-to-chemofree-future-for-subset-of-rectal-cancer-patients?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4585","GSK.UK","GSK","PCOM","LU1829250122.USD","BK4532","GSKH","BK4588","BK4122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651195870","title":"J.P. Morgan Sticks to Their Sell Rating for GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651195870","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651195870?lang=en_us&edition=fundamental","pubTime":"2026-07-13 13:55","pubTimestamp":1783922118,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Zain Ebrahim maintained a Sell rating on GlaxoSmithKline today and set a price target of £17.00. According to TipRanks, Ebrahim...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-their-sell-rating-for-glaxosmithkline-gsk-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-their-sell-rating-for-glaxosmithkline-gsk-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650139214","title":"Guggenheim Remains a Hold on GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650139214","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650139214?lang=en_us&edition=fundamental","pubTime":"2026-07-10 23:45","pubTimestamp":1783698318,"startTime":"0","endTime":"0","summary":"Guggenheim analyst maintained a Hold rating on GlaxoSmithKline yesterday. The company’s shares closed today at p1,959.50. In addition to Guggenheim...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-remains-a-hold-on-glaxosmithkline-gsk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-remains-a-hold-on-glaxosmithkline-gsk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4532","GSK","LU1829250122.USD","BK4007","GSKH","GSK.UK","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650182181","title":"GSK says Hansoh Pharma announces positive phase 3 results for Ris-Rez in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2650182181","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650182181?lang=en_us&edition=fundamental","pubTime":"2026-07-10 19:10","pubTimestamp":1783681857,"startTime":"0","endTime":"0","summary":"GSK (GSK) plc licensor Hansoh Pharmaceutical Group announced that ARTEMIS-008, its pivotal phase III trial evaluating risvutatug rezetecan, or Ris-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsk-says-hansoh-pharma-announces-positive-phase-3-results-for-ris-rez-in-china-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsk-says-hansoh-pharma-announces-positive-phase-3-results-for-ris-rez-in-china-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4585","GSK.UK","GSK","LU1829250122.USD","BK4532","GSKH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121894437","title":"Revenue Revision at Frontier Biotech Highlights Channel Pressures as Operating Losses Widen","url":"https://stock-news.laohu8.com/highlight/detail?id=1121894437","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121894437?lang=en_us&edition=fundamental","pubTime":"2026-07-10 14:21","pubTimestamp":1783664489,"startTime":"0","endTime":"0","summary":"Frontier Biotech has responded to the Shanghai Stock Exchange's 2025 annual report inquiry letter, providing clarifications on issues including revenue recognition adjustments, distributor inventory,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK.UK","BK4532","LU1829250122.USD","BK4588","BK4585","GSKH","GSK","SPHQ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650397178","title":"GSK price target raised to 1,950 GBp from 1,900 GBp at Deutsche Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2650397178","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650397178?lang=en_us&edition=fundamental","pubTime":"2026-07-10 03:35","pubTimestamp":1783625740,"startTime":"0","endTime":"0","summary":"Deutsche Bank raised the firm’s price target on GSK (GSK) to 1,950 GBp from 1,900 GBp and keeps a Hold rating on the shares. Published first on The...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsk-price-target-raised-to-1950-gbp-from-1900-gbp-at-deutsche-bank-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsk-price-target-raised-to-1950-gbp-from-1900-gbp-at-deutsche-bank-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DB","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650978583","title":"GSK US President Acquires Notional ADS Under Executive Savings Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2650978583","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650978583?lang=en_us&edition=fundamental","pubTime":"2026-07-09 22:32","pubTimestamp":1783607547,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has provided an update. GSK disclosed that Maya Martinez-Davis, President of US operations and a person discharging m...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-us-president-acquires-notional-ads-under-executive-savings-plan-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-us-president-acquires-notional-ads-under-executive-savings-plan-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","BK4007","BK4532","GSK","GSKH","BK4588","LU1829250122.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650940152","title":"GSK Adds Philips CEO Roy Jakobs to Board as Independent Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2650940152","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650940152?lang=en_us&edition=fundamental","pubTime":"2026-07-09 17:02","pubTimestamp":1783587750,"startTime":"0","endTime":"0","summary":"The latest announcement is out from GlaxoSmithKline ( ($GB:GSK) ). GSK has appointed Roy Jakobs, the current chief executive of health technology g...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-adds-philips-ceo-roy-jakobs-to-board-as-independent-director?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-adds-philips-ceo-roy-jakobs-to-board-as-independent-director?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","EKG","GSK.UK","GSKH","BK4007","BK4585","LU1829250122.USD","BK4532","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115056703","title":"SBP GROUP Shares Surge Over 5% in Early Trading on Deepened Strategic Alliance with GLAXOSMITHKLINE","url":"https://stock-news.laohu8.com/highlight/detail?id=1115056703","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115056703?lang=en_us&edition=fundamental","pubTime":"2026-07-09 10:21","pubTimestamp":1783563660,"startTime":"0","endTime":"0","summary":"Shares of SBP GROUP (01177) climbed more than 5% during the morning session. At the time of writing, the stock was up 5.39% to HK$5.08, with a turnover of HK$239 million. Expanding a Strategic...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1521","IE00BZ08YS42.EUR","BK4532","GSKH","BK4007","GSK","BK1515","BK1589","01177","BK4588","HK0000165453.HKD","GSK.UK","IE00BZ08YT58.USD","BK4585","LU1829250122.USD","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650291696","title":"Alector Ends GSK Collaboration, Retires Hercules Capital Debt","url":"https://stock-news.laohu8.com/highlight/detail?id=2650291696","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650291696?lang=en_us&edition=fundamental","pubTime":"2026-07-09 04:32","pubTimestamp":1783542774,"startTime":"0","endTime":"0","summary":"Alector ( ($ALEC) ) has provided an announcement. On October 21, 2025, Alector reported that its Phase 3 INFRONT-3 trial of latozinemab in frontote...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alector-ends-gsk-collaboration-retires-hercules-capital-debt?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alector-ends-gsk-collaboration-retires-hercules-capital-debt?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSKH","LU1829250122.USD","GSK","FXED","BK4532","GSK.UK","BK4007","HTGC","BIZD","PBDC","BK4135","BK4585","BK4588","PEX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650861990","title":"GSK’s New RSV/hMPV Vaccine Trial Adds Momentum to Its Respiratory Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2650861990","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650861990?lang=en_us&edition=fundamental","pubTime":"2026-07-09 00:32","pubTimestamp":1783528353,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GSK steps up its respiratory vaccine push with a new study, NCT07628049...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-new-rsv-hmpv-vaccine-trial-adds-momentum-to-its-respiratory-portfolio?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-new-rsv-hmpv-vaccine-trial-adds-momentum-to-its-respiratory-portfolio?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","BK4588","BK4585","GSKH","GSK","BK4007","BK4532","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gsk.com","stockEarnings":[{"period":"1week","weight":-0.0204},{"period":"1month","weight":-0.0149},{"period":"3month","weight":-0.0994},{"period":"6month","weight":0.067},{"period":"1year","weight":0.3604},{"period":"ytd","weight":0.0491}],"compareEarnings":[{"period":"1week","weight":0.0126},{"period":"1month","weight":0},{"period":"3month","weight":0.0757},{"period":"6month","weight":0.0913},{"period":"1year","weight":0.2132},{"period":"ytd","weight":0.1069}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.586957,"avgChangeRate":0.013809},{"month":2,"riseRate":0.478261,"avgChangeRate":0.001243},{"month":3,"riseRate":0.608696,"avgChangeRate":0.019112},{"month":4,"riseRate":0.659574,"avgChangeRate":0.030828},{"month":5,"riseRate":0.404255,"avgChangeRate":-0.008644},{"month":6,"riseRate":0.595745,"avgChangeRate":0.010234},{"month":7,"riseRate":0.531915,"avgChangeRate":0.003467},{"month":8,"riseRate":0.586957,"avgChangeRate":0.005806},{"month":9,"riseRate":0.521739,"avgChangeRate":0.005973},{"month":10,"riseRate":0.521739,"avgChangeRate":0.013062},{"month":11,"riseRate":0.478261,"avgChangeRate":0.009917},{"month":12,"riseRate":0.608696,"avgChangeRate":0.014188}],"exchange":"NYSE","name":"GlaxoSmithKline PLC","nameEN":"GlaxoSmithKline PLC","securityTypeName":"DR","adrRate":"1:2"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GlaxoSmithKline PLC(GSK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GlaxoSmithKline PLC,GSK,GlaxoSmithKline PLC股票,GlaxoSmithKline PLC股票老虎,GlaxoSmithKline PLC股票老虎国际,GlaxoSmithKline PLC行情,GlaxoSmithKline PLC股票行情,GlaxoSmithKline PLC股价,GlaxoSmithKline PLC股市,GlaxoSmithKline PLC股票价格,GlaxoSmithKline PLC股票交易,GlaxoSmithKline PLC股票购买,GlaxoSmithKline PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GlaxoSmithKline PLC(GSK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}